<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02018575</url>
  </required_header>
  <id_info>
    <org_study_id>0019850580 amendment</org_study_id>
    <nct_id>NCT02018575</nct_id>
  </id_info>
  <brief_title>Metabolic Availability of Lysine From White Maize</brief_title>
  <official_title>Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From White Maize Protein, in Young Adult Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our objective is to determine the metabolic availability of Lysine in white maize using the
      indicator amino acid oxidation (IAAO) technique in adult men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our objective is to determine the metabolic availability of Lysine in white maize. 7 young,
      healthy, male adults will receive graded levels (29, 37,46 and 54%) of lysine requirement of
      35 mg/kg/d as a crystalline AA mixture and a porridge of white cornmeal protein respectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic Availability of Lysine</measure>
    <time_frame>Baseline</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic Availability of Lysine</measure>
    <time_frame>15 mins after intake of the fourth hourly meal (before tracer infusion)</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Metabolic availability of Lysine</measure>
    <time_frame>30 mins after intake of the fourth hourly meal (before tracer infusion)</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolic Availability of Lysine</measure>
    <time_frame>45 mins after intake of the fourth hourly meal (before tracer infusion)</time_frame>
    <description>3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolic Availability of Lysine</measure>
    <time_frame>Post Tracer Infusion (between 150 and 240 min of tracer infusion)</time_frame>
    <description>4 breath samples will be taken to provide F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>levels of lysine intake.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomly selected levels of lysine intake which are lower than the lysine requirement (previously derived).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Crystalline Lysine Amino Acid Mix</intervention_name>
    <description>Crystalline Lysine from Amino Acid Mixture in amount of 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.</description>
    <arm_group_label>levels of lysine intake.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>White corn meal porridge</intervention_name>
    <description>A cornmeal porridge including 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.</description>
    <arm_group_label>levels of lysine intake.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Adult males (20-49 years old)

        Exclusion Criteria:

          -  A history of recent weight loss or illness

          -  Use of any medication at the time of entry into the study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul B Pencharz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children, Toronto, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G-1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2013</study_first_posted>
  <last_update_submitted>November 11, 2016</last_update_submitted>
  <last_update_submitted_qc>November 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Dr. Paul Pencharz</investigator_full_name>
    <investigator_title>Professor of Paediatrics and Nutritional Sciences (Emeritus) University of Toronto, Senior Scientist Research Institute, The Hospital for Sick Children</investigator_title>
  </responsible_party>
  <keyword>lysine</keyword>
  <keyword>bioavailability</keyword>
  <keyword>amino acids</keyword>
  <keyword>corn</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

